Insider · CIK 0001815260
Athyrium Opportunities III Co-Invest 1 LP
Files at BIOR (BIORA THERAPEUTICS, INC.). First filing -, latest -.
In brief
Athyrium Opportunities III Co-Invest 1 LP files SEC Form 4 as director and 10% owner at BIOR (BIORA THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Athyrium Opportunities III Co-Invest 1 LP has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award 11.00% / 13.00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | - | - | - | - | Dec 16, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer 11.00%/13. 00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | - | - | - | - | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award 11.00%/13. 00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | - | - | - | - | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer Warrantderivativeindirect: See footnotes | -323,886 | - | - | 0 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +323,886 | - | - | 323,886 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer Warrantderivativeindirect: See footnotes | -500,249 | - | - | 0 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +500,249 | - | - | 500,249 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer Warrantderivativeindirect: See footnotes | -2,085,372 | - | - | 0 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +2,085,372 | - | - | 2,085,372 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer Warrantderivativeindirect: See footnotes | -5,039,236 | - | - | 0 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +5,039,236 | - | - | 5,039,236 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer Warrantderivativeindirect: See footnotes | -457,250 | - | - | 0 | Aug 14, 2024 |
| Aug 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +457,250 | - | - | 457,250 | Aug 14, 2024 |
| Jul 3, 2023 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +457,250 | - | - | 457,250 | Jul 8, 2024 |
| Jul 2, 2024 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award 11.00%/13.00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | - | - | - | - | Jul 5, 2024 |
| Dec 18, 2023 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award 11.00% / 13.00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | +6,953,000 | - | - | 6,953,000 | Dec 20, 2023 |
| Dec 18, 2023 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +2,085,372 | - | - | 2,085,372 | Dec 20, 2023 |
| Dec 18, 2023 | BIOR BIORA THERAPEUTICS, INC. | DDisposition to issuer 7.25% Convertible Senior Notes due 2025derivativeindirect: See footnotes | -53,500,000 | - | - | 0 | Dec 20, 2023 |
| Dec 18, 2023 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award 11.00% / 13.00% Convertible Senior Secured Notes due 2028derivativeindirect: See footnotes | +10,430,000 | - | - | 17,383,000 | Dec 20, 2023 |
| Dec 18, 2023 | BIOR BIORA THERAPEUTICS, INC. | AGrant or award Warrantderivativeindirect: See footnotes | +5,039,236 | - | - | 5,039,236 | Dec 20, 2023 |
Questions about Athyrium Opportunities III Co-Invest 1 LP
Answered from the filings on this page, as of the latest one.
Is Athyrium Opportunities III Co-Invest 1 LP buying or selling?
Athyrium Opportunities III Co-Invest 1 LP has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Athyrium Opportunities III Co-Invest 1 LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Athyrium Opportunities III Co-Invest 1 LP has 0.
Where does Athyrium Opportunities III Co-Invest 1 LP file Form 4?
Athyrium Opportunities III Co-Invest 1 LP has filed Form 4 at BIOR (BIORA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.